News

Discover MIRAILAB BIOSCIENCE's Innovative NMN Supplements

Discover MIRAILAB BIOSCIENCE's Innovative NMN Supplements

MIRAILAB BIOSCIENCE Launches NMN Supplements in Singapore

MIRAILAB BIOSCIENCE Inc., a trailblazer in the health supplement industry, is making waves with the launch of its first NMN (?-Nicotinamide Mononucleotide) supplements in Singapore. This innovative company, founded in Tokyo and led by CEO Megumi Tanaka, has partnered with Global Ocean Distribution Pte Ltd to facilitate the distribution of its renowned product line named “MIRAI LAB.” The supplements are available for eager customers on Shopee, one of Singapore's leading e-commerce platforms.

What is NMN and Its Benefits?

NMN is a naturally occurring compound derived from nicotinamide, a variant of vitamin B3, which plays a fundamental role in various cellular processes. Despite being synthesized in the human body, levels of NMN decline as we age, which may contribute to diminished cellular functions and various age-related challenges.

Research has highlighted NMN's connection to longevity, specifically its ability to influence the activity of sirtuins, a group of proteins linked to aging and cellular health. This nutrient has captured the attention of researchers and health enthusiasts alike, particularly for its potential in combating lifestyle diseases frequently encountered by middle-aged and older adults, including skin aging and muscle weakness.

Pioneering the NMN Market

Since its inception, MIRAILAB BIOSCIENCE has been at the forefront of NMN supplement innovation. The company launched the first NMN product globally in 2015, setting a standard for quality with a purity level of 99.7%. This commitment to excellence has solidified its reputation among researchers, even featuring in significant clinical trials supported by esteemed institutions, showcasing its reliability and effectiveness.

MIRAI Lab products have gained popularity, especially among affluent consumers in Japan and China, and now they are expanding their reach to markets such as the United States, UAE, and Singapore.

Providing Value through the Official Shopee SG Store

Ensuring Affordability and Access

The launch of the official Shopee SG store aims to deliver quality products to Singaporean consumers at an accessible price point. The store prides itself on offering prices comparable to those found in Japan, avoiding common mark-ups often seen with imported goods.

Flexibility with Pricing

Recognizing the challenges posed by fluctuating currency rates, the team at MIRAILAB adjusts prices dynamically to ensure that all customers receive fair pricing, making health and wellness supplements more attainable.

Local Stock for Quick Delivery

To enhance customer experience, MIRAILAB ensures that its products are stocked locally in Singapore. This strategy allows for expedient deliveries, making the purchasing process seamless for customers eager to start their journey with NMN supplementation.

Authenticity and Trust

As an authorized retailer, the official Shopee SG store guarantees that all products are genuine and of the highest quality. When it comes to health supplements, consumers are encouraged to buy only from reputable sources to ensure safety and efficacy.

Exciting Product Offerings

MIRAI LAB provides a range of premium quality products, including:

  • NMN 9000 Pure VIP Plus
  • Aqua Pet

With the promise of adding more products soon, the store aims to cater to a wider audience, attracting those interested in high-quality wellness solutions.

Special Promotions for Customers

In conjunction with Shopee's promotions, MIRAILAB BIOSCIENCE provides various recurring deals:

  • 10% OFF Bulk Discount: Available for purchases of two or more items.
  • Additional Coupons: Offered during regular Shopee promotions for even greater savings.
  • Free Shipping: Applicable on orders exceeding a specified amount.

Through these initiatives, MIRAILAB BIOSCIENCE emphasizes its dedication to customer satisfaction and accessibility.

Frequently Asked Questions

What are NMN supplements used for?

NMN supplements are primarily used for promoting cellular health, anti-aging benefits, and overall wellness, addressing age-related challenges.

How does NMN work in the body?

NMN helps increase levels of NAD+ in the body, which is crucial for energy metabolism, DNA repair, and regulating various cellular processes.

Where can I purchase MIRAI LAB NMN products?

You can purchase NMN products through the official Shopee SG store, where reliable and authentic products are offered.

What makes MIRAILAB BIOSCIENCE's NMN unique?

MIRAILAB's NMN products are distinguished by their high purity levels and pioneering market presence, which assures customers of their efficacy and quality.

Are there any promotions currently available?

Yes, MIRAILAB offers various promotions, including discounts on bulk purchases, additional coupons during special events, and free shipping over certain order amounts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading